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Abstract: 
Background: The autoimmune disease T1DM (Type 1 diabetes mellitus) consider as 
important endocrine disorder described by the damage of beta cells of pancreatic islets. There 
is confirmation the IL-10 is a significant player on both immunity arms: innate and adaptive 
immunity. This study aimed to determined the essential role of IL-10 serum in the T1DM al-
diwanyah patients as a vital immune factor for prevention and treatment of T1DM. 
Patients and methods: A total of (33) patients (T1DM) patient. The cohort was divided into 
two groups according to gender (17 female, 16 male).in addition to (15) healthy control group 
to measure the serum level of IL-10 by ELISA. Data was evaluated by T-test analysis at (P 
<0.05) significant level. 
Results: the date displayed high significant mean of serum level for T1DM patients (424.9 ± 
161.6 pg/ml) in comparative with healthy control (29.1 ± 7.1 pg/ml) at the (P<0.05) level, and 
could be seen from the result the serum level of IL-10 for the male  group (454.8 ± 156.5 
pg/ml) significantly higher than female group (  47.4 ± 22.1 pg/ml) at the (P<0.05) level.  
Conclusions: In conclusion IL-10 has been acknowledged as an important pleiotropic 
immunomodulatory cytokines were elevated under regulation of internal environment and 
homeostasis and involved in maintaining immune homeostasis . 
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Introduction: 
        The (T1DM) is considering as a vital endocrine disease characterized by the damage of 
beta cells of pancreatic islets lead to the insulin deficiency [1]. The disease can noticed at 
different age, but is often occurred in early adulthood and adolescence. Although exact cause 
of T1D is unidentified; nonetheless, immunologic, genetic and environmental factors be 
responsible for the disease.[2,3] ,and there are numerous studies explained a correlation 
between the  abnormalities in the function of T cell  and the occurrence of diabetes mellitus 
[4,5] .There is growing evidence to suggest that altered Th1/Th2 balance and related 
cytokines have a significant effect on the development of autoimmune disorder  such as 
T1DM [6]. There are numerous studies focused upon using several mediators (such as 
antibodies, cytokines, and macrophage precursors) that making Th2 active completely using 
variable grades of achievement to avoid the disease (7). the cytokine IL-10 Involved in the 
therapies through the immunomodulatory effect, and so other  research refers to Th2 
cytokines ( IL-10 and IL-4) as protector from T1DM in NOD mice either by reverse T-cell 
unresponsiveness or via decreased Th1 within T-cell infiltrated pancreatic islet [8]. 
The pluripotent effect and immunoregulatory properties of IL-10 introduced it as a vital 
player on both innate and adaptive immunity. [9] by limiting the inflammatory response 
which could otherwise cause tissue damage; where act to avoid the effect of inflammatory 
[10]. A number of studies referred to IL-10 as a trigger of humeral immunity through 
inducing the expression of class II MHC on B cells and talk into production of antibodies [9]. 
Moreover, IL-10 can conserve the transcription factor Fox3 expression on Treg cells and 
suppressive roles in mice [11],so the IL-10 is a recognized as immunostimulatory in addition 
to immunosuppressive and anti-inflammatory properties [12].The purpose of this research was 
to estimate the interleukin (IL-10) serum level in T1DM paitents, and their relationship with 
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Subject  and Method 
Thirty-five Iraqi T1DM (19 female, 16 male) with (15 healthy) matched to T1DM patients 
group by age and gender contained within this research. Where they attending the Center of 
Diabetes and Endocrinology in al-diwanyah through the period of November -2015 to March-
2016, from the venous blood collect Four milliliters blood from each subject (patients and 
controls). The drawn blood was moved into plain test tubes, then separated the serum by 
centrifugation at 2500 rpm in 10 min., separated into aliquots and kept at-20°C until used. IL-
10 were measured by ELISA using human IL-10kit (R&D system). The samples were collect 
from (patients and control) group after an overnight fasting period.  
Statistical Analysis : 
The Student's t-test was used to assess the differences between study groups. All parameter 
were assessed as means ±SE. the significant was fixed at (P˂0.05) level.   
Result: 
Simple statistical analysis was used to explain the concentration of IL-10 serum level in the 
investigated patients (424.9 pg/ml) comparative with healthy group (29.1 pg/ml ), where the 
T1DM patients have  significantly increased IL-10 serum level  compared to health group 
(P1=0.042) as shown in table 1 and figure 1 .  
 
Table 1: Means of interleukin-10 serum level in T1DM and healthy group 
 No. 
Mean ± SE(pg\ml) 
IL-10 
Healthy 15 29.1 ± 7.18 
T1 DM 35 424.9 ± 161.6 




 * (P<0.05) 
 
 
Figure-1: serum levels of interleukin-10 in T1DM and healthy group. 
And so, a significant difference between male ( male 454.8 pg/ml )  and female(47.4 pg/ml) 
groups in interleukin-10 serum level was evident at the level (P  > 0.05), as presented in table 
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Figure-2: serum levels of IL-10 in male and female T1DM  patients 
 
Discussion  
        The current study found that IL-10 serum level in T1DM patients higher than healthy 
group and this result disagreement with the some research, which determine the lower IL-10 
serum level in T1DM patients (13,14).neither Geerlings et al. (31) nor Foss-Freitas et al. [35] 
determined differences in IL-10 serum level  between diabetic patients and control 
individuals, and agreement  with  other study noticed that concentration  of IL-10 peripheral 
blood form T1DM was  significantly higher than those in normal group[15,16]. 
The significant result for this study showed an elevated level of serum IL-10 in T1DM group 
compared with healthy controls, where it was across to many other reports, which establish 
that T1DM could be treated by stimulation the T helper 2 cells or via treatment with T helper 
2  interleukin(IL-10 and IL-4) [8], and then limited the cascade of proinflammatory 
interleukin activation [10] and, downregulated T cell-mediated immune responses [17]. 
Schloot and his group referred to an first elevated level of serum IL-10 was detected primarily 
at T1DM patients , but after that get down the IL-10 level when the T1DM was developed, so 
that approving the fact that IL-10 was necessary  for diabetes developing (18). IL-10 is 
inducer , act as B-cell activator, increases MHC class II expression on B-cells, therefore 
stimulating periinsulitis and insulitis (19) ,thus inducing the  collecting of macrophages and 
B-cells (20), and because of its role as cytotoxic T-cell activator agent , IL-10 may induce 
activated T-cells and its essential for an early phase of diabetes (21). Anyway, T helper 2 
interleukin can no longer be regarded as"protective" of T1DM. 
So, the high level of Interleukin-10 in critically ill and septic patients saved them from 
death [22], whereas the decrease concentration was establish in non-survivors [23]. In 
contrast, other reports pointed against the anti-inflammatory action of Th2 cytokines. Th2 
cytokines (IL-10 but not IL-4) were presented to be involved in T1DM disease by assistance 
the infiltration of mononuclear cells in pancreas and producing strong and generalized 
 No. 
Mean ± SE(pg\ml) 
IL-10 





female 19 47.4 ± 22.1 
 
 




 *(P  > 0.05) 
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pancreatitits and insulitis related with islet destruction in NOD mice (24). The other 
researchers explained the initial systemic cure with exogenous murine Interleukin-10 can 
prevent T1DM in NOD mice, but the (intra islet) expression speed up the onset of disease 
(25).The abnormalities in IL-10 concentration or role have been related with T1DM in both 
humans and NOD mice (14, 26).It was clearly that “Th2-induced” element of anti B cell 
immunity due to the experiment, which describe the local construction of Interlukin-10, but 
not Interlukin-4, enhanced autoimmune damage of b islet cells (27). 
Functionally, Th2 exert their effects by direct or indirect pathway. Interlukin -10  may 
encourage necrosis by obstruction of the microvasculature, thereby resulting in hypoxia and 
reducing the viability of the larger islets (28). 
In addition this study explain a strong relationship between IL-10 cytokines and 
patients gender , in the Instead of there were no differences in T1DM occurrence between 
male and female, the T1DM incident in male and female are equally affected in young 
populations, even though most common autoimmune diseases disproportionately affect 
females [29], but when described  the serum level between two gender in this study , it was 
clearly that a  significant differences between them, may be due to the effect of testosterone 
hormone, where Liva and Voskuhl had observed the testosterone hormone acted straight upon 
T helper cells to rise Interlukine-10 expression [30], In agreement with IL-10 anti-
inflammatory activity, this explain  the elevated serum level of IL-10 in protected the 
critically patients from death [22], whereas decrease serum levels were found in non-
survivors[23]and this clarify the high mortality in women with T1DM than man, as mention  
Huxley and his colleagues, that excess risk of mortality is much greater in women with type 1 
diabetes in compared with men[31].  
In conclusion, IL-10 has been recognized as important pleiotropic immunomodulatory 
cytokines were elevated under the regulation of internal environment and homeostasis and 
involved in maintaining immune homeostasis under steady-state conditions. 
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